Topic Highlight
Copyright ©2012 Baishideng Publishing Group Co.
World J Gastroenterol. May 14, 2012; 18(18): 2161-2171
Published online May 14, 2012. doi: 10.3748/wjg.v18.i18.2161
Table 3 Summary of studies reporting on adverse bleeding events
StudyObserved adverse eventAscertainmentResults
Bhatt et al[25]Composite of upper gastrointestinal bleeding (of known and unknown origin): overt bleeding, ulcers, symptomatic erosions, obstruction, perforation or decrease in hemoglobin of 2 g/dLEndoscopic and radiologic confirmation (in known origin subgroup)Significative reduction of upper gastrointestinal bleeding in the omeprazole treated group (1.1% against 2.9% under placebo; HR 0.34, 95% CI: 0.18-0.63)
Ray et al[27]Hospitalization for bleeding at a gastroduodenal site (excluding angiodysplasia) or other gastrointestinal and non-gastrointestinal sitesValidated diagnostic codes with PPV of 91%Adjusted 50% reduction of hospitalization in the PPI treated group (HR 0.50, 95% CI: 0.39-0.65), no significant difference concerning bleeding at other sites
van Boxel et al[14]Occurence of complicated or non complicated peptic ulcer diseaseICD-9 diagnostic codesLow incidence (0.7% with PPI against 0.2%) but significant increase of peptic ulcer disease in the PPI treated group even after multivariable adjusting (HR 4.76, 95% CI: 1.18-19.17)
Charlot et al[28]Hospitalization for gastrointestinal bleedingICD-9 diagnostic codesNo reduction between the clopidogrel with PPI and clopidogrel alone group
Harjai et al[29]TIMI major bleeding: intracranial hemorrage or a ≥ 5 g/dL decrease in hemoglobine TIMI minor bleeding: observed blood loss with decrease ≥ 3 g/dL in hemoglobineGuthrie Health System databaseNo significant difference between the clopidogrel with PPI and clopidogrel alone group
Simon et al[30]In-hospital major bleeding (not specified) or need for blood transfusionFAST-MI registryNo significant difference between the clopidogrel with PPI and clopidogrel alone group